Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole

Neurology

Volumn 52, Issue 9, 1999, Pages 1908-1910

  Frucht, S ^a,d   Rogers, J D ^b   Greene, P E ^a   Gordon, M F ^b   Fahn, S ^c  

^a New York State Psychiat Inst and New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^d NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRAMIPEXOLE; ROPINIROLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOPAMINERGIC SYSTEM; DOWN REGULATION; HUMAN; INSOMNIA; MALE; NARCOLEPSY; PRIORITY JOURNAL; SEDATION; SLEEP DISORDER; SOMNOLENCE; TRAFFIC ACCIDENT;

EID: 0032975093     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.9.1908     Document Type: Article

References (5)

1. Gottwald MD, Bainbridge JL, Dowling GA, Aminoff MJ, Alldredge BK. New pharmacotherapy for Parkinson's disease. Ann Pharmacother 1997;31:1205-1217.
2. Parkinson Study Group. Safety and efficacy of pramipexole in early Parkinson's disease. JAMA 1997;278:125-130.
3. Sethi KD,. O'Brien CF, Hammerstad JP, et al. Ropinirole for the treatment of early Parkinson's disease. Arch Neurol 1998; 55:1211-1216.
4. Rye DB, Bliwise DL. Movement disorders specific to sleep and the nocturnal manifestations of waking movement disorders. In: Watts RL, Koller WC, eds. Movement disorders. New York: McGraw-Hill, 1997:687-713.
5. Fry JM. Treatment modalities for narcolepsy. Neurology 1998; 50(suppl 1):S43-S48.